Campaign
AuriGen Medical 4
Med Tech
AuriGen Medical, a clinical-stage MedTech firm, is transforming stroke prevention with its Zenith device. Promising clinical results position it for rapid growth.
€
500,000 Funding goal
€
1,035,506 Invested
165Investors
Company Summary :
CLOSING MONDAY 2nd DECEMBER
AuriGen Medical is transforming stroke prevention with its Zenith device, designed to address key unmet market needs.
Key highlights:
- Promising Clinical Results: Initial First-in-Human trials show complication-free outcomes, and strong feedback from experienced LAAO users emphasizes Zenith’s competitive advantages..
- Growing Market Potential: LAAO market projected to expand from $2B in 2023 to $10B by 2032
- Competitive Advantage: Zenith tackles thrombus and leaks with real-time detection, repositioning, and a self-closing membrane for easier implantation.
- Market Opportunity: Positioned to address unmet needs, competing with leaders in the growing LAAO market, with plans for rapid entry and global expansion backed by strong data.